Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Symptom Management in Bipolar Depression: Realistic Expectations and Strategies for Improvement

Joseph F. Goldberg, MD, and Roger McIntyre, MD, FRCPC, discuss strategies and expectations for symptom management in bipolar depression, including the value of measurement-based care in optimizing patient outcomes.
Joseph F. Goldberg, MD
Roger McIntyre, MD, FRCPC
Released: November 2, 2022

In this episode, Joseph F. Goldberg, MD, and Roger McIntyre, MD, FRCPC, shed light on the symptom improvement timeline in bipolar depression. This is a topic made more complex when factoring in individual patient characteristics and comorbidities, but the 2 experts have astute insights on how to tailor a management plan based on such factors. They cover symptom management and improvement from a variety of angles, including evaluating improvement in functionality and mood, guidance on follow-up and dose adjustment schedules, the utility of measurement-based care, and—of most importance—how to best communicate with and support a patient while they work towards remission and recovery.

Information on this Educational Activity

Faculty

Joseph F. Goldberg, MD

Clinical Professor of Psychiatry
Department of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York

Joseph F. Goldberg, MD: consultant/advisor/speaker: BioXcel, Jazz, Lundbeck, Otsuka, Sage, Sunovion; fees for non-CME/CE services: AbbVie, Alkermes, Intra-Cellular Therapies, Sunovion.
Roger McIntyre, MD, FRCPC

Professor of Psychiatry and Pharmacology
Department of Psychiatry/Pharmacology
University of Toronto
Head, Mood Disorders Psychopharmacology Unit
Department of Psychiatry
Toronto, Canada

Roger McIntyre, MD, FRCPC: researcher: CIHR/GACD/National Natural Science Foundation of China (NSFC), Milken Institute; consultant/speaker: Alkermes, AbbVie, Atai Life Sciences, Axsome, Bausch Health, Boehringer Ingelheim, Biogen, Eisai, IntraCellular, Janssen, Kris, Lundbeck, Mitsubishi Tanabe, Neumora Therapeutics, Neurocrine, NewBridge Pharmaceuticals, Novo Nordisk, Otsuka, Pfizer, Purdue, Sanofi, Sunovion, Takeda; executive role: Braxia Scientific Corporation.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie Inc.
Intra-Cellular Therapies, Inc.

Related Content

Board-certified psychiatric pharmacist provides information on the pharmacokinetics and administration of long-acting injectable antipsychotics, from Clinical Care Options (CCO)

Austin Campbell, PharmD, BCCP Released: January 24, 2023

In this on-demand webcast, an expert faculty explores updates on identifying and managing tardive dyskinesia.

Leslie Citrome, MD, MPH Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: 1.0 AAPA Category 1 CME Credit Psychologists: 1.0 APA CE Credit Social Workers: 1.0 ACE CE Credit Released: January 23, 2023 Expired: January 22, 2024

In this on-demand webcast, an expert faculty describes the current and emerging treatment options for major depression

Greg W. Mattingly, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: 1.0 AAPA Category 1 CME Credit Psychologists: 1.0 APA CE Credit Social Workers: 1.0 ACE CE Credit Released: January 20, 2023 Expired: January 19, 2024

Expert presentation on current and emerging treatments for bipolar depression with a focus on treatment with monoaminergic antidepressants, mood stabilizers, and specific second-generation antipsychotics, from Clinical Care Options (CCO)

Joseph F. Goldberg, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: 1.0 AAPA Category 1 CME Credit Psychologists: 1.0 APA CE Credit Social Workers: 1.0 ACE CE Credit Released: January 20, 2023 Expired: January 19, 2024

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings